244 related articles for article (PubMed ID: 24488099)
1. High sphingomyelin levels induce lysosomal damage and autophagy dysfunction in Niemann Pick disease type A.
Gabandé-Rodríguez E; Boya P; Labrador V; Dotti CG; Ledesma MD
Cell Death Differ; 2014 Jun; 21(6):864-75. PubMed ID: 24488099
[TBL] [Abstract][Full Text] [Related]
2. Lipid-induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders.
Gabandé-Rodríguez E; Pérez-Cañamás A; Soto-Huelin B; Mitroi DN; Sánchez-Redondo S; Martínez-Sáez E; Venero C; Peinado H; Ledesma MD
EMBO J; 2019 Jan; 38(2):. PubMed ID: 30530526
[TBL] [Abstract][Full Text] [Related]
3. Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type A.
Long Y; Xu M; Li R; Dai S; Beers J; Chen G; Soheilian F; Baxa U; Wang M; Marugan JJ; Muro S; Li Z; Brady R; Zheng W
Stem Cells Transl Med; 2016 Dec; 5(12):1644-1655. PubMed ID: 27484861
[TBL] [Abstract][Full Text] [Related]
4. Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A.
Carsana EV; Lunghi G; Prioni S; Mauri L; Loberto N; Prinetti A; Zucca FA; Bassi R; Sonnino S; Chiricozzi E; Duga S; Straniero L; Asselta R; Soldà G; Samarani M; Aureli M
J Mol Neurosci; 2022 Jul; 72(7):1482-1499. PubMed ID: 35727525
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelin-induced inhibition of the plasma membrane calcium ATPase causes neurodegeneration in type A Niemann-Pick disease.
Pérez-Cañamás A; Benvegnù S; Rueda CB; Rábano A; Satrústegui J; Ledesma MD
Mol Psychiatry; 2017 May; 22(5):711-723. PubMed ID: 27620840
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein D-mediated preservation of lysosomal function promotes cell survival and delays motor impairment in Niemann-Pick type A disease.
Pascua-Maestro R; Corraliza-Gomez M; Fadrique-Rojo C; Ledesma MD; Schuchman EH; Sanchez D; Ganfornina MD
Neurobiol Dis; 2020 Oct; 144():105046. PubMed ID: 32798728
[TBL] [Abstract][Full Text] [Related]
7. Sphingomyelin 16:0 is a therapeutic target for neuronal death in acid sphingomyelinase deficiency.
Gaudioso Á; Jiang X; Casas J; Schuchman EH; Ledesma MD
Cell Death Dis; 2023 Apr; 14(4):248. PubMed ID: 37024473
[TBL] [Abstract][Full Text] [Related]
8. Excess sphingomyelin disturbs ATG9A trafficking and autophagosome closure.
Corcelle-Termeau E; Vindeløv SD; Hämälistö S; Mograbi B; Keldsbo A; Bräsen JH; Favaro E; Adam D; Szyniarowski P; Hofman P; Krautwald S; Farkas T; Petersen NH; Rohde M; Linkermann A; Jäättelä M
Autophagy; 2016 May; 12(5):833-49. PubMed ID: 27070082
[TBL] [Abstract][Full Text] [Related]
9. Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease.
Dodge JC; Clarke J; Treleaven CM; Taksir TV; Griffiths DA; Yang W; Fidler JA; Passini MA; Karey KP; Schuchman EH; Cheng SH; Shihabuddin LS
Exp Neurol; 2009 Feb; 215(2):349-57. PubMed ID: 19059399
[TBL] [Abstract][Full Text] [Related]
10. Neurons regulate the esterification of bioactive lipid mediators in the brain of acid sphingomyelinase deficient mice.
Taha AY; Gaudioso Á; Moran-Garrido M; Camunas-Alberca SM; Bachiller-Hernández J; Sáiz J; Ledesma MD; Barbas C
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110896. PubMed ID: 37956788
[TBL] [Abstract][Full Text] [Related]
11. Neuropathology of the acid sphingomyelinase knockout mouse model of Niemann-Pick A disease including structure-function studies associated with cerebellar Purkinje cell degeneration.
Macauley SL; Sidman RL; Schuchman EH; Taksir T; Stewart GR
Exp Neurol; 2008 Dec; 214(2):181-92. PubMed ID: 18778708
[TBL] [Abstract][Full Text] [Related]
12. Accurate differentiation of neuronopathic and nonneuronopathic forms of Niemann-Pick disease by evaluation of the effective residual lysosomal sphingomyelinase activity in intact cells.
Graber D; Salvayre R; Levade T
J Neurochem; 1994 Sep; 63(3):1060-8. PubMed ID: 8051547
[TBL] [Abstract][Full Text] [Related]
13. An Early-Onset Neuronopathic Form of Acid Sphingomyelinase Deficiency: A SMPD1 p.C133Y Mutation in the Saposin Domain of Acid Sphingomyelinase.
Ota S; Noguchi A; Kondo D; Nakajima Y; Ito T; Arai H; Takahashi T
Tohoku J Exp Med; 2020 Jan; 250(1):5-11. PubMed ID: 31941852
[TBL] [Abstract][Full Text] [Related]
14. Degradation of fluorescent and radiolabelled sphingomyelins in intact cells by a non-lysosomal pathway.
Levade T; Vidal F; Vermeersch S; Andrieu N; Gatt S; Salvayre R
Biochim Biophys Acta; 1995 Oct; 1258(3):277-87. PubMed ID: 7548198
[TBL] [Abstract][Full Text] [Related]
15. Brain pathology in Niemann Pick disease type A: insights from the acid sphingomyelinase knockout mice.
Ledesma MD; Prinetti A; Sonnino S; Schuchman EH
J Neurochem; 2011 Mar; 116(5):779-88. PubMed ID: 21214563
[TBL] [Abstract][Full Text] [Related]
16. Solving the secretory acid sphingomyelinase puzzle: Insights from lysosome-mediated parasite invasion and plasma membrane repair.
Andrews NW
Cell Microbiol; 2019 Nov; 21(11):e13065. PubMed ID: 31155842
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type A.
Samaranch L; Pérez-Cañamás A; Soto-Huelin B; Sudhakar V; Jurado-Arjona J; Hadaczek P; Ávila J; Bringas JR; Casas J; Chen H; He X; Schuchman EH; Cheng SH; Forsayeth J; Bankiewicz KS; Ledesma MD
Sci Transl Med; 2019 Aug; 11(506):. PubMed ID: 31434754
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological reversion of sphingomyelin-induced dendritic spine anomalies in a Niemann Pick disease type A mouse model.
Arroyo AI; Camoletto PG; Morando L; Sassoe-Pognetto M; Giustetto M; Van Veldhoven PP; Schuchman EH; Ledesma MD
EMBO Mol Med; 2014 Mar; 6(3):398-413. PubMed ID: 24448491
[TBL] [Abstract][Full Text] [Related]
19. Acid Sphingomyelinase, a Lysosomal and Secretory Phospholipase C, Is Key for Cellular Phospholipid Catabolism.
Breiden B; Sandhoff K
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445706
[TBL] [Abstract][Full Text] [Related]
20. Intraparenchymal injections of acid sphingomyelinase results in regional correction of lysosomal storage pathology in the Niemann-Pick A mouse.
Yang WW; Dodge JC; Passini MA; Taksir TV; Griffiths D; Schuchman EH; Cheng SH; Shihabuddin LS
Exp Neurol; 2007 Oct; 207(2):258-66. PubMed ID: 17686472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]